124 related articles for article (PubMed ID: 33161372)
1. Incidence trends of esophageal cancer in the Czech Republic by histological subtype and stage and prescription rate of acid suppressing drugs.
Kroupa R; Katinova I; Pavlik T; Kunovsky L; Prochazka V; Borilova Linhartova P; Packova B; Kala Z; Dolina J
Cancer Epidemiol; 2020 Dec; 69():101853. PubMed ID: 33161372
[TBL] [Abstract][Full Text] [Related]
2. [Malignant tumors of the esophagus in the Czech Republic].
Duda M; Adamcík L; Dusek L; Skrovina M; Jínek T
Rozhl Chir; 2012 Mar; 91(3):132-40. PubMed ID: 22881077
[TBL] [Abstract][Full Text] [Related]
3. Gastroesophageal reflux disease, proton-pump inhibitor use and Barrett's esophagus in esophageal adenocarcinoma: Trends revisited.
Lada MJ; Nieman DR; Han M; Timratana P; Alsalahi O; Peyre CG; Jones CE; Watson TJ; Peters JH
Surgery; 2013 Oct; 154(4):856-64; discussion 864-6. PubMed ID: 24074425
[TBL] [Abstract][Full Text] [Related]
4. Trends in incidence and survival of esophageal cancer in Korea: Analysis of the Korea Central Cancer Registry Database.
Shin A; Won YJ; Jung HK; Kong HJ; Jung KW; Oh CM; Choe S; Lee J
J Gastroenterol Hepatol; 2018 Dec; 33(12):1961-1968. PubMed ID: 29802647
[TBL] [Abstract][Full Text] [Related]
5. Trends in Esophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma Incidence in the United States from 1992 to 2019.
Liu KS; Raza SA; El-Serag HB; Thrift AP
Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551535
[TBL] [Abstract][Full Text] [Related]
6. Trends in the incidence and survival of patients with esophageal cancer: A SEER database analysis.
He H; Chen N; Hou Y; Wang Z; Zhang Y; Zhang G; Fu J
Thorac Cancer; 2020 May; 11(5):1121-1128. PubMed ID: 32154652
[TBL] [Abstract][Full Text] [Related]
7. Incidence Trends of Esophageal and Gastric Cancer Subtypes by Race, Ethnicity, and Age in the United States, 1997-2014.
Islami F; DeSantis CE; Jemal A
Clin Gastroenterol Hepatol; 2019 Feb; 17(3):429-439. PubMed ID: 29902641
[TBL] [Abstract][Full Text] [Related]
8. Trends in esophageal adenocarcinoma incidence and mortality.
Hur C; Miller M; Kong CY; Dowling EC; Nattinger KJ; Dunn M; Feuer EJ
Cancer; 2013 Mar; 119(6):1149-58. PubMed ID: 23303625
[TBL] [Abstract][Full Text] [Related]
9. Is young-onset esophageal adenocarcinoma increasing in Japan? An analysis of population-based cancer registries.
Saito E; Yano T; Hori M; Yoneoka D; Matsuda T; Chen Y; Katanoda K
Cancer Med; 2022 Mar; 11(5):1347-1356. PubMed ID: 35077026
[TBL] [Abstract][Full Text] [Related]
10. The Epidemiology of Esophageal Adenocarcinoma.
Coleman HG; Xie SH; Lagergren J
Gastroenterology; 2018 Jan; 154(2):390-405. PubMed ID: 28780073
[TBL] [Abstract][Full Text] [Related]
11. Patterns and trends in esophageal cancer mortality and incidence in Europe (1980-2011) and predictions to 2015.
Castro C; Bosetti C; Malvezzi M; Bertuccio P; Levi F; Negri E; La Vecchia C; Lunet N
Ann Oncol; 2014 Jan; 25(1):283-90. PubMed ID: 24356640
[TBL] [Abstract][Full Text] [Related]
12. Esophageal cancer subtypes and survival rates at the VA Caribbean Healthcare System: a 10-year experience.
González Ortiz DI; Toro DH
Bol Asoc Med P R; 2009; 101(3):14-7. PubMed ID: 20120980
[TBL] [Abstract][Full Text] [Related]
13. International trends in esophageal cancer incidence rates by histological subtype (1990-2012) and prediction of the rates to 2030.
Lin Y; Wang HL; Fang K; Zheng Y; Wu J
Esophagus; 2022 Oct; 19(4):560-568. PubMed ID: 35689719
[TBL] [Abstract][Full Text] [Related]
14. The influence of deprivation and ethnicity on the incidence of esophageal cancer in England.
Cooper SC; Day R; Brooks C; Livings C; Thomson CS; Trudgill NJ
Cancer Causes Control; 2009 Oct; 20(8):1459-67. PubMed ID: 19533393
[TBL] [Abstract][Full Text] [Related]
15. The Role of Gastroesophageal Reflux and Other Factors during Progression to Esophageal Adenocarcinoma.
Hazelton WD; Curtius K; Inadomi JM; Vaughan TL; Meza R; Rubenstein JH; Hur C; Luebeck EG
Cancer Epidemiol Biomarkers Prev; 2015 Jul; 24(7):1012-23. PubMed ID: 25931440
[TBL] [Abstract][Full Text] [Related]
16. The incidence of esophageal adenocarcinoma continues to rise: analysis of period and birth cohort effects on recent trends.
Thrift AP; Whiteman DC
Ann Oncol; 2012 Dec; 23(12):3155-3162. PubMed ID: 22847812
[TBL] [Abstract][Full Text] [Related]
17. Incidence trends in oesophageal cancer by histological type: An updated analysis in Sweden.
Xie SH; Mattsson F; Lagergren J
Cancer Epidemiol; 2017 Apr; 47():114-117. PubMed ID: 28258029
[TBL] [Abstract][Full Text] [Related]
18. Temporal trends of Barrett's oesophagus and gastro-oesophageal reflux and related oesophageal cancer over a 10-year period in England and Wales and associated proton pump inhibitor and H2RA prescriptions: a GPRD study.
Alexandropoulou K; van Vlymen J; Reid F; Poullis A; Kang JY
Eur J Gastroenterol Hepatol; 2013 Jan; 25(1):15-21. PubMed ID: 23022985
[TBL] [Abstract][Full Text] [Related]
19. Secular Trends in Incidence of Esophageal Cancer in Taiwan from 1985 to 2019: An Age-Period-Cohort Analysis.
Tsai MC; Chou YC; Lee YK; Hsu WL; Tang CS; Chen SY; Huang SP; Chen YC; Lee JM
Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497327
[TBL] [Abstract][Full Text] [Related]
20. Statin use reduces risk of esophageal adenocarcinoma in US veterans with Barrett's esophagus: a nested case-control study.
Nguyen T; Duan Z; Naik AD; Kramer JR; El-Serag HB
Gastroenterology; 2015 Nov; 149(6):1392-8. PubMed ID: 26208896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
